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A B S T R A C T
Background
Pressure ulcers, which are localised injury to the skin or underlying tissue, or both, occur when people are unable to reposition
themselves to relieve pressure on bony prominences. Pressure ulcers are often difficult to heal, painful and impact negatively on the
individual’s quality of life. The cost implications of pressure ulcer treatment are considerable, compounding the challenges in providing
cost effective, efficient health service delivery. International guidelines suggest that to prevent and manage pressure ulcers successfully
a team approach is required. Therefore, this review has been conducted to clarify the role of wound-care teams in the prevention and
management of pressure ulcers.
Objectives
To assess the impact of wound-care teams in preventing and treating pressure ulcers in people of any age, nursed in any healthcare
setting.
Search methods
In April 2015 we searched: The Cochrane Wounds Group Specialised Register; The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library); Ovid MEDLINE; Ovid MEDLINE (In-Process & Other Non-Indexed Citations); Ovid EM-
BASE and EBSCO CINAHL. There were no restrictions with respect to language, date of publication or study setting.
Selection criteria
We considered RCTs that evaluated the effect of any configuration of wound-care teams in the treatment or prevention of pressure
ulcers.
Data collection and analysis
Two review authors independently assessed titles and, where available, abstracts of the studies identified by the search strategy for their
eligibility. We obtained full versions of potentially relevant studies and two review authors independently screened these against the
inclusion criteria.
Main results
We identified no studies that met the inclusion criteria.
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Authors’ conclusions
We set out to evaluate the RCT evidence pertaining to the impact of wound-care teams on the prevention and management of pressure
ulcers. However, no studies met the inclusion criteria. There is a lack of evidence concerning whether wound-care teams make a
difference to the incidence or healing of pressure ulcers. Well-designed trials addressing important clinical, quality of life and economic
outcomes are justified, based on the incidence of the problem and the high costs associated with pressure ulcer management.
P L A I N L A N G U A G E S U M M A R Y
Wound-care teams for preventing and treating pressure ulcers (bed sores)
Background
Pressure ulcers (bed sores) are wounds that occur on the skin or underlying tissues. These wounds commonly occur in people who
cannot move themselves. The wounds are difficult to heal. Therefore, it is important to try to prevent them from occurring in the first
place. However, when they occur, it is also important to manage the wounds properly. A wound-care team is expected to deliver better
outcomes for people with these wounds. This is when care is compared to the person being managed by only one health professional
alone.
Review question
We wanted to discover the impact that a wound-care team has on the prevention or healing of pressure ulcers. We were interested in
studies that included a team that focused on pressure ulcer prevention. We were also interested in studies that focused on treatment of
pressure ulcers. The study could include people of any age. The setting where the care was provided could include any type of hospital
or nursing home or the person’s own home. The study could include people with pressure ulcers or at risk of developing pressure ulcers.
What we found
We searched for studies on 7 April 2015 and found no studies. Because we found no studies to include in this review, we cannot say
whether wound-care teams improve the prevention or management of pressure ulcers. Therefore, the impact of wound-care teams on
the prevention and management of pressure ulcers needs to be studied.
The evidence of this review is up-to-date as of 7 April 2015.
B A C K G R O U N D
Description of the condition
A pressure ulcer is defined as a localised injury to the skin or
underlying tissue, or both, usually over a bony prominence, as a
result of pressure, or pressure in combinationwith shear. A number
of contributing or confounding factors are also associated with
pressure ulcers, the significance of which have yet to be elucidated
(NPUAP/EPUAP/PPPIA 2014). Pressure ulcers are commonly
classified according to the depth of tissue damage, ranging from
non-blanching erythemaof intact skin (tissue redness that does not
turn white when pressed) to full-scale tissue destruction (NPUAP/
EPUAP/PPPIA 2014).
A large number of risk factors may contribute to pressure ulcer
development (Moore 2008), and in keeping with the NPUAP/
EPUAP/PPPIA 2014 guidance, Coleman 2013 argued that a com-
plex interplay of these factors increases the probability of pressure
ulcer development. There are three primary risk factors of partic-
ular significance: mobility and activity, impaired perfusion (circu-
lation problems, possibly due to diabetes) and fragile skin or exist-
ing or previous pressure ulcers (Coleman 2013). These risk factors
mean that certain populations, such as the very old and people
with an inability to reposition themselves freely, are at greater risk
of developing pressure ulcers (Moore 2012).
’Prevalence’ refers to the number of people with a pressure ulcer at
a point in time, or during a specific time period, while ’incidence’
concerns the rate at which new pressure ulcers develop in a defined
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population in a specific time period (Beaglehole 1993). Prevalence
and incidence studies indicate that pressure ulcers are common.
Indeed, prevalence rates range from 0.38% to 53.2% (Lahmann
2006; Capon 2007; Vanderwee 2007; Keelaghan 2008; Tubaishat
2010; Kwong 2011;Moore 2012; Igarashi 2013; Stevenson 2013;
Moore 2013a), and incidence rates vary from 1.9% to 71.6%
across Europe, Japan, China, the Middle East, the USA, Australia
andCanada (Jolley 2004;Defloor 2005; Scott 2006; Kwong 2011;
Moore 2011; Igarashi 2013; Moore 2013a). Mean prevalence was
reported as 20.9%within the acute-care setting, and 11.7%within
the long-stay setting; among people in hospice the mean figure
was 35.7%, but dropped to 0.04% to 4% for people nursed in the
community (Moore 2013a). Incidence figures among the different
care settings are similar to prevalence figures. For example, mean
incidence of pressure ulcers in the acute-care setting was 18%
and for the long-stay setting was 6.6%. There is little information
available about pressure ulcer incidence within the community-
care setting (Moore 2013a).
The impact of pressure ulcers on the individual is profound, span-
ning the physical, emotional and social domains of life (Gorecki
2009). This impact is largely influenced by factors related to the
individual themselves, the healthcare professional and the envi-
ronment of care delivery (Gorecki 2012). Fundamentally, people
living with pressure ulcers experience significant anxieties that re-
late to their experiences of the ulcer, for example, the presence of
unrelieved intractable pain, in addition to challenges to their abil-
ity to cope with the demands that treatments impose upon them
(Gorecki 2012).
From a European perspective, pressure ulcer management absorbs
between 4% and 5% of the annual healthcare budget, with nurse
or healthcare-assistant time accounting for up to 90% of the over-
all costs (Posnett 2009). In the USA, pressure ulcers cost between
USD 9.1 billion to USD 11.6 billion per year (EUR 6.7 billion to
EUR 8.5 billion), with estimates in 2007 that each pressure ulcer
addsUSD43,180 (EUR31,580) in costs to a hospital stay (Agency
for Healthcare Research and Quality 2011).Within the acute-care
setting in Australia in 2005, median opportunity costs for pressure
ulcers were estimated at AUD 285 million (EUR 202 million)
(Graves 2005). The human and economic drain on healthcare
systems is compounded by the fact that healthcare professionals
and clinicians are often not trained in prevention and treatment of
pressure ulcers or remain in systems where multidisciplinary and
integrated care processes are not in place, or both (Moore 2013b).
Indeed, a higher incidence and prevalence of pressure ulcers has
been noted in settings where there are poor organisational strate-
gies for preventing and managing pressure ulcers (Igarashi 2013).
Description of the intervention
Since the late 1990s there have been reports of the impact that
multidisciplinary wound-care teams can have on pressure ulcer
prevention and management in clinical practice (Doan-Johnson
1998; Granick 1998; Dolynchuk 2000). During this era, it was
noted that there was an increasing number of formal and informal
multidisciplinary wound-care teams that adhered to specific care
protocols (Doan-Johnson 1998).
Once the best available evidence on the most appropriate way to
improve wound-related outcomes had been synthesised and inte-
grated with expert opinion, multidisciplinary wound-care teams
were created in many settings through the consensus of healthcare
professionals with an interest in wound care (Dolynchuk 2000;
Gottrup 2003; Haworth 2009). The aim of these teams was to
focus on delivering high-quality, holistic and patient-specific skin
care to improve wound-related outcomes and to prevent the de-
terioration of the integrity of people’s tissues (Dolynchuk 2000;
Gottrup 2003; Haworth 2009).
The exact composition of the multidisciplinary wound-care team
is mainly determined by the person’s needs, thus, potentially, any
healthcare professional can be a member if it is in the person’s best
interest (Gottrup 2004; Clark 2007; Zulkowski 2007; Haworth
2009). Therefore, it is evident that multidisciplinary wound-care
teams can consist of different healthcare professionals. Teams’ key
roles include overseeing the pressure ulcer-related education of
staff, people with or at risk of pressure ulcers and carers; under-
taking pressure ulcer-related research; and supervising the person’s
pressure ulcer prevention and management strategies (Dolynchuk
2000; Ryan 2003; Gottrup 2004; Woo 2008).
While a number of different approaches to the formation of multi-
disciplinary wound-care teams have been reported in clinical prac-
tice, they are all said to have had a positive impact on the wound
prevention and management care that people receive (Gottrup
2003; Gottrup 2004; Haworth 2009). Indeed, in one hospital, the
multidisciplinary wound-care teamwas found to have reduced the
prevalence of pressure ulcers by 18% over three years, and in a dif-
ferent hospital the team reduced the pressure ulcer prevalence by
15% in one year (Granick 1998). In another setting, the multidis-
ciplinary wound-care team achieved a high rate of wound healing
as 68% of 103 people with chronic wounds achieved complete or
almost complete wound healing, and only 2% of the people had
the recurrence of an old wound (Donnelly 2000). However, the
studies referred to here lack the rigor required to determine the
impact of the introduction of the multidisciplinary wound-care
team clearly, because they use a pre-post test design with signifi-
cant time gaps between the pre and post test, and outcome data
were collected using an audit methodology.
How the intervention might work
The intervention in this review was the wound-care team: this
review considered the impact that these teams had on pressure
ulcer prevention and management. We defined the wound-care
team as a formally constituted team of healthcare professionals
who worked closely to supervise the pressure ulcer prevention and
management care of people in hospitals or community-care set-
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ting, or both. The teammay have been multidisciplinary (e.g. any
combination of dietician, nurse, medical doctor, physiotherapist,
occupational therapist) or uni-disciplinary (e.g. team composed
entirely of nurses). The team may have focus on a simple strategy
(e.g. a turning-only regimen) or a complex strategy (e.g. dietary,
mobilisation, education).
The World Health Organization (WHO) argued that collabora-
tive practice strengthens healthcare systems and improves health
outcomes (WHO 2010). Furthermore, the WHO suggested that
such an approach to care delivery is key to optimising outcomes of
individual people with or at risk of pressure ulcers (WHO 2010),
thereby enhancing overall health and social gain. A lack of inte-
grated care systems and functioning multidisciplinary teams com-
pounds the suffering of people with or at risk of pressure ulcers
and increases demands on already overstretched health budgets
(Moore 2005). Conversely, structured multidisciplinary interven-
tions, such as interdisciplinary collaboration and education, im-
prove outcomes of people with or at risk of pressure ulcers and
overall health service delivery (Apelqvist 2000).
The multidisciplinary wound-care team is expected to deliver bet-
ter outcomes compared to the alternative, where a person’s pressure
ulcer prevention and management-related care is delivered by one
group of healthcare professionals (e.g. just nurses alone), without
the insight, expertise and active participation of fellow healthcare
professionals (e.g. physiotherapists, occupational therapists, phar-
macists and doctors). There are a number of factors that can con-
tribute to the formation of pressure ulcers, or can affect the healing
of pressure ulcers, which are perhaps best addressed by pooling the
expertise of different healthcare professionals in order to enhance
the prevention and management-related outcomes of people with
or at risk of pressure ulcers. Thus, the multidisciplinary wound-
care team may have a positive impact on these outcomes because
it brings together a range of healthcare professionals with different
expertise in order to plan and deliver care to prevent and manage
pressure ulcers in a holistic way that is designed to suit the person’s
individual needs.
Why it is important to do this review
International guidelines suggest that to prevent and manage pres-
sure ulcers successfully a team approach is required (Agency for
Healthcare Research and Quality 2011; NPUAP/EPUAP/PPPIA
2014). Furthermore, a team approach to care delivery is advocated
by the WHO (WHO 2010). Although there have been many re-
ports about the positive impact that wound-care teams have had
on pressure ulcer prevention and management, many of these re-
ports appear to have been underpinned by anecdotal evidence,
or have been subjected to little critical scrutiny, so, overall, the
precise impact of wound-care teams is unclear. Therefore, it was
important to search and appraise the literature systematically in
order to determine the impact of teams on the prevention and
management of pressure ulcers.
O B J E C T I V E S
To assess the impact of wound-care teams on preventing and treat-
ing pressure ulcers in people of any age, nursed in any healthcare
setting.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We planned to include randomised controlled trials (RCTs) that
evaluated the effect of any configuration of wound-care teams in
the treatment or prevention of pressure ulcers. For this interven-
tion, there was a high probability that hospitals, or wards within
hospitals, rather than individuals, would be randomised. Con-
sequently, we planned to also include cluster-RCTs if the clus-
ter design had been properly accounted for in the trial’s analy-
sis. We planned to include cluster-RCTs if information was avail-
able in the paper, or from the investigator, that would have al-
lowed us to conduct an appropriate analysis. We planned to ex-
clude trials that did not use a validated instrument (such as the
NPUAP/EPUAP/PPPIA 2014 definitions) to assess pressure ul-
cers. We also planned to exclude studies using quasi-randomisa-
tion, controlled before-and-after studies and interrupted-time-se-
ries studies. We would have considered cross-over studies eligible
if data from the first period, before cross-over, were reported sep-
arately.
Types of participants
People of any age, in any setting (hospitals, nursing homes, resi-
dential care, rehabilitation centres) who were at risk of develop-
ing a pressure ulcer (as identified through either a structured or
unstructured risk assessment, or by clinical judgement alone), or
who had an existing pressure ulcer (of any stage), were eligible for
inclusion.
Types of interventions
The intervention of interest was a team that focused on pressure
ulcer prevention or treatment, or both. The team may have been
multidisciplinary (e.g. any combination of dietician, nurse, med-
ical doctor, physiotherapist, occupational therapist) or uni-disci-
plinary (e.g. team composed entirely of nurses). The team may
have focused on a simple strategy (e.g. a turning-only regimen) or
a complex strategy (e.g. dietary, mobilisation, education).
We planned to compare the impact of the wound-care team on
pressure ulcer prevention and management against the delivery of
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care to prevent or manage pressure ulcers by an individual health-
care professional.
Types of outcome measures
We planned to consider primary and secondary outcomes under
two categories, prevention and treatment.
Primary outcomes
Prevention studies
• Pressure ulcer incidence (the proportion of participants
developing any new pressure ulcer(s) of any grade).
Treatment studies
The primary outcome for treatment studies was complete healing,
but this may have been measured and reported in several ways by
trial authors. Therefore, we planned to include RCTs that reported
any of the following:
• an objective measure of pressure ulcer healing such as
absolute or percentage change in pressure ulcer area or volume
over time; proportion of individuals with pressure ulcers healed
at the completion of the trial period; or healing rate (we planned
to accept trials with any length of follow-up, we also planned to
adjust for any differences in our analyses);
• time to complete wound healing (using methods of survival
analysis and expressing the intervention effect as a hazard ratio
(HR)).
Secondary outcomes
Prevention studies
• Resource use (including costs associated with the team and
those costs associated with dressings and other additional
interventions where reported).
• Length of hospital stay.
• Satisfaction (using any validated scale).
• Morbidity (e.g. infection).
Treatment studies
• Pain (measured at any time with any validated instrument
e.g. visual analogue scale).
• All-cause mortality.
• Health-related quality of life (using any validated measure
such World Health Organization Quality of Life (WHOQOL)-
BREF, 36-item Short Form (SF-36), 12-item Short Form (SF-
12)).
• Resource use (including costs associated with the team and
those associated with dressings and other additional
interventions where reported).
• Morbidity (e.g. infection, proportion requiring surgical
repair).
• Mortality (pressure ulcer-related or infection-related
mortality).
Search methods for identification of studies
Electronic searches
We searched the following electronic databases to identify reports
of relevant randomised clinical trials:
• The Cochrane Wounds Group Specialised Register
(searched 7 April 2015);
• The Cochrane Central Register of Controlled Trials
(CENTRAL) (The Cochrane Library 2015, Issue 3);
• Ovid MEDLINE (1946 to 6 April 2015);
• Ovid MEDLINE (In-Process & Other Non-Indexed
Citations) (6 April 2015);
• Ovid EMBASE (1974 to 6 April 2015);
• EBSCO CINAHL (1982 to 7 April 2015).
We used the following search strategy in The Cochrane Central
Register of Controlled Trials (CENTRAL):
#1 MeSH descriptor: [Patient Care Team] explode all trees
#2 ((care or health or healthcare or medical or nursing or interdis-
ciplinary or multidisciplinary or wound* or turn*) next team*):
ti,ab,kw
#3 (“team nursing” or nurse-led or nurse-centred or team-based):
ti,ab,kw
#4 {or #1-#3}
#5 MeSH descriptor: [Pressure Ulcer] explode all trees
#6 (pressure next (ulcer* or sore* or injur*)):ti,ab,kw
#7 (decubitus next (ulcer* or sore*)):ti,ab,kw
#8 ((bed next sore*) or bedsore):ti,ab,kw
#9 {or #5-#8}
#10 #4 and #9
The search strategies for the Ovid MEDLINE, Ovid EMBASE
andEBSCOCINAHLcan be found inAppendix 2.We combined
the Ovid MEDLINE search with the Cochrane Highly Sensitive
Search Strategy for identifying randomised trials in MEDLINE:
sensitivity- and precision-maximising version (2008 revision) (
Lefebvre 2011).We combined the EMBASE search with theOvid
EMBASE filter developed by the UK Cochrane Centre (Lefebvre
2011). We combined the CINAHL searches with the trial filters
developed by the Scottish Intercollegiate Guidelines Network (
SIGN 2013). There were no restrictions with respect to language,
date of publication or study setting.
We also searched the following clinical trials registries:
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• ClinicalTrials.gov (https://clinicaltrials.gov/) (searched 7
April 2015);
• WHO International Clinical Trials Registry (ICTR) (http:/
/apps.who.int/trialsearch/default.aspx) (searched 7 April 2015);
• The EU Clinical Trials Register (
www.clinicaltrialsregister.eu/) (searched 7 April 2015).
Searching other resources
We planned to search reference lists of all included studies and
other relevant publications, such as systematic reviews and guide-
lines. We contacted experts in the field to identify any completed
or ongoing trials. We planned to contact the authors of relevant
publications to identify any completed or ongoing trials. We also
performed manual searches of conference proceedings to identify
authors and papers related primarily to wound-care teams for the
prevention or treatment, or both, of pressure ulcers.
Data collection and analysis
We performed this systematic review according to guidance in the
Cochrane Handbook for Systematic Reviews of Interventions (Green
2011).
Selection of studies
Two review authors (ZM and RS) independently screened all titles
and abstracts retrieved by the searches, and excluded those that
clearly did not meet the inclusion criteria. We obtained the full
text of one remaining paper, which three review authors (ZM,
JW and RS) assessed for eligibility (Stern 2014). We subsequently
excluded this study.
Data extraction and management
We planned to extract data from eligible studies using a data ex-
traction sheet developed for this purpose. Specifically, we planned
to extract the following information:
• author, title, source;
• date of study, country of origin;
• care setting;
• inclusion and exclusion criteria;
• baseline participant characteristics;
• sample size calculation;
• number of participants randomised to each arm;
• study design details;
• trial quality (method of randomisation; allocation
concealment; blinding of the participant and outcome assessor;
completeness of reporting);
• intervention details (specifically team composition and
focus of the intervention), concurrent intervention(s);
• primary and secondary outcomes (with definitions);
• length of follow-up;
• loss to follow-up;
• outcomes data for primary and secondary outcomes (by
group);
• intention-to-treat (ITT) analysis;
• funding source;
• conflicts of interest.
Two review authors were to extract data independently; we would
have resolved any differences in opinion by discussion and, where
necessary, reference to the Wounds Group editorial base. If data
were missing from reports, we intended to make attempts to con-
tact study authors to obtain the missing information. We planned
to enter data into Review Manager 5 software (RevMan 2011).
Assessment of risk of bias in included studies
We planned to assess included studies using The Cochrane Col-
laboration tool for assessing risk of bias (Higgins 2011a). This
tool addresses six specific domains: sequence generation, alloca-
tion concealment, blinding, incomplete outcome data, selective
outcome reporting and other issues (e.g. extreme baseline imbal-
ance). We planned to present our assessment of risk of bias using
a ’Risk of bias’ summary figure, which shows a summary of all of
the risk of bias items. We planned to assess the comparability of
individually randomised trials however, no studies met the inclu-
sion criteria (Higgins 2011b).
Measures of treatment effect
For dichotomous outcomes (e.g. number of wounds healed), we
planned to calculate the risk ratio (RR)with 95%confidence inter-
vals (CI). For continuously distributed outcome data (e.g. health-
related quality of life), we planned to use the mean difference
(MD) with 95% CIs.
We planned to report time-to-event data (e.g. time to complete
wound healing) as HR where possible, in accordance with the
methods described in the Cochrane Handbook for Systematic Re-
views of Interventions (Deeks 2011). For statistically significant ef-
fects in binary outcomeswe planned to calculate number needed to
treat for an additional beneficial outcome (NNTB) or additional
harmful outcome (NNTH). Where skewness was suspected, and
if scale data had finite upper and lower limits, we planned to use
the easy ’rule of thumb’ calculation to test for skewness. That is, if
the standard deviation (SD), when doubled, was greater than the
mean, it was unlikely that the mean is the centre of the distribu-
tion (Altman 1996), and we planned not to enter the data into
any meta-analysis. If we found relevant data that were skewed, we
planned to present the data in ’Other data’ tables.
Unit of analysis issues
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We planned to check unit of analysis issues if we included clus-
ter-RCTs. If required, and if sufficient data were available, we
planned to recalculate results using the appropriate unit of analysis
(Higgins 2011b). We also planned to note whether participants,
or ulcers, had been randomised. Where there was evidence that
multiple ulcers on a single person had been analysed incorrectly
(i.e. by considering outcomes for multiple ulcers as independent),
we planned seek further information from the trialist.
For cluster-RCTs that used analysis methods to account for the
clustering, we planned to extract effect sizes and standard errors
(SE) from the appropriate analysis.
Dealing with missing data
Where possible, we planned to perform all analyses using the ITT
principle, that is, participants were to be analysed according to
their allocated treatment group. Where it appeared that data were
excluded from the analyses, we planned to contact authors for these
missing data. If data remained missing, despite our best efforts
to obtain them, we would have assumed that those missing from
the analysis of dichotomous data had a negative outcome (e.g.
developed a pressure ulcer or did not completely heal).
For continuous data, where SDs weremissing, we planned to com-
pute them from SE using the formula SD = SE x
√
N (Higgins
2011c). If this was not possible, we planned to impute SDs from
similar continuous outcome data and use sensitivity analyses to
assess the impact of the assumptions we made (i.e. using small or
large SDs) (Higgins 2011b). Where results were reported for all
participants, but it was unclear how many people were originally
randomised, we planned to use an available-case analysis.
Assessment of heterogeneity
We planned to assess clinical heterogeneity in terms of how com-
parable trials were according to their inclusion criteria, interven-
tion and outcome measures. We planned to assess statistical het-
erogeneity by visual inspection of forest plots, using the Chi2 test
with significance set at 0.10, and using the I2 statistic, which ex-
amines the percentage of total variation across studies that is due to
heterogeneity rather than chance (Higgins 2003).Where I2 values
were 40% or less, we would have considered heterogeneity to be
low, and where I2 values exceeded 75%, we would have considered
it to be high.
Assessment of reporting biases
We planned to assess reporting bias using guidelines in the
Cochrane Handbook for Systematic Reviews of Interventions (Stern
2011). If enough studies were available for a meaningful assess-
ment of publication bias, we planned to construct a funnel plot
of primary outcomes to test for asymmetry. We would also have
considered selective reporting (i.e. reporting some outcomes and
not others) in our assessment of reporting bias.
Data synthesis
Initially we planned to present a structured narrative summary
of the study reviewed. Quantitative data were to be entered into
Review Manager for analysis (RevMan 2011). If included studies
were sufficiently similar in terms of population, inclusion criteria,
interventions and outcomes (including the times at which out-
comes were assessed in both intervention and treatment trials),
we planned to pool the data statistically, using meta-analysis. We
planned to use a fixed-effect model if appropriate (i.e. when I2
values were 40% or less), otherwise we planned to use a random-
effects model. We planned not to pool data where the I2 values
were greater than 75%. A summary of results from the data syn-
thesis and assessment of quality of evidence were to be included
in a ’Summary of findings’ table for the main comparisons. We
planned to combine cluster-RCTs with individually randomised
trials in the samemeta-analysis, using subgroups to assess the effect
of the randomisation method. We planned to explore the possi-
bility of important differences in the effects being evaluated in the
different types of trials before conducting ameta-analysis (Higgins
2011b). We planned to include trials that reported time-to-event
data as continuous, using means or medians, but we planned to
report results from these trials in the narrative and we planned not
to include these results in any meta-analyses.
’Summary of findings’ tables
To assess the overall body of evidence, we planned to develop a
’Summary of findings’ table using GRADE profiler (GRADEpro).
We planned to assess the quality of the body of evidence against
five principle domains: limitations in design and implementation;
indirectness of evidence or generalisability of findings; inconsis-
tency of results - for example unexplained heterogeneity and in-
consistent findings; imprecision of results where confidence inter-
vals are wide; and other potential biases, for example publication
bias or high manufacturer involvement (Schunemann 2011).
Subgroup analysis and investigation of heterogeneity
If substantial heterogeneity had existed between studies for the
primary outcomes (i.e. when the I2 statistic exceeds 50%), we
planned to explore reasons for heterogeneity. We envisaged that
the number of studies meeting our inclusion criteria may be low.
Consequently, to avoid type 1 errors, we planned to conduct a
minimal number of sub-analyses that would include the following,
if possible:
• acute care versus residential care;
• type of wound-care team (e.g. single discipline versus
multidisciplinary);
• type of intervention (single-factor versus multi-factorial).
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Sensitivity analysis
We planned to perform a sensitivity analysis by excluding those
studies assessed as having a high risk of bias in the key domains of
’generating the randomisation sequence’, ’allocation concealment’
and ’blinding of outcome assessment’. We also planned to explore
the effect of unpublished studies, small studies (fewer than 100
participants) and cluster trials, where the analysis was not at the
same level as the allocation (i.e. allocation by cluster and analysis
by individual).
R E S U L T S
Description of studies
Results of the search
The search yielded 198 citations. ZM and RS examined the ab-
stracts of all papers, independently, to assess for potential rele-
vance. Following this assessment, no papers met the inclusion cri-
teria. RS contacted 28 experts in the field enquiring about fur-
ther potential papers, and no further papers were identified. JW
identified one paper on searching Clinicaltrials.com (Stern 2014),
which we excluded (see Characteristics of excluded studies).
Included studies
No study met the inclusion criteria.
Excluded studies
We excluded one study from this review as this paper involved a
cluster randomised step-wedge design and was analysed in such a
way that we were unable to extract data for any of our outcomes
(Stern 2014).We contacted the trial investigator but he was unable
to provide us with further information (see Characteristics of
excluded studies).
Risk of bias in included studies
Allocation
No study met the inclusion criteria.
Blinding
No study met the inclusion criteria.
Incomplete outcome data
No study met the inclusion criteria.
Selective reporting
No study met the inclusion criteria.
Other potential sources of bias
No study met the inclusion criteria.
Effects of interventions
No study met the inclusion criteria.
D I S C U S S I O N
Pressure ulcers are common, costly and impact negatively on
health-related quality of life. The incidence and prevalence of pres-
sure ulcers are often used as measures of quality of care provided
for people with or at risk of pressure ulcers and as such many
healthcare providers are investing significantly in measures aimed
at reducing the occurrence of these wounds. Recent developments
in healthcare delivery have placed a greater emphasis on healthcare
providers working together in teams with the aim of enhancing
clinical outcomes. Within the field of pressure ulcer prevention
and management, such teams have become more prevalent. One
publication exploring the concept of a team approach to wound
care noted, following an iterative review of the literature, that
there were 24 pressure ulcer studies published in this field (Moore
2014). The majority of studies were descriptive and observational
with the exception of one randomised intervention trial which
was excluded from this review as this paper involved a cluster ran-
domised step-wedge design and was analysed in such a way that
we were unable to extract data for any of our outcomes. Team
Interventions were multifaceted, lacked homogeneity and mainly
described the impact of these interventions without the use of a
control group. A reduction in pressure ulcer prevalence after team
intervention was reported in all of the studies; however, there was a
lack of clarity surrounding which elements, or group of elements,
contributed most to the outcome so other concurrent factors may
have influenced pressure ulcer reduction, for example, changes in
clinical practice, electronicmedical records and new technology or
speciality beds (Moore 2014). The variety of methods employed
within the studies included by Moore 2014 impact on bias, which
reduces the ability to draw conclusions that would be useful to
the reader. Therefore, as yet, the precise impact of teams has not
be assessed from a rigorous systematic review perspective. There-
fore, we set out to evaluate the RCT evidence pertaining to the
impact of wound-care teams on the prevention and management
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of pressure ulcers. No study met the inclusion criteria, therefore,
it remains unclear whether wound-care teams make a difference
to the incidence or healing of pressure ulcers. From a health pol-
icy perspective, this is important given the drive for increased in-
ter-professional collaboration in education and practice, which is
thought to be the key to providing the best care, enhancing clini-
cal and health-related outcomes, and strengthening the healthcare
system as a whole (WHO 2010).
Summary of main results
No study met the inclusion criteria.
Overall completeness and applicability of
evidence
No study met the inclusion criteria.
Quality of the evidence
No study met the inclusion criteria.
Potential biases in the review process
We followed clearly described procedures to prevent potential bias
in the review process. This included a careful literature search and
the methods we used were transparent and reproducible. None of
the review authors has any conflict of interest. It is possible that
trials published in journals that were outside our search strategy
may have been missed.
Agreements and disagreements with other
studies or reviews
There have been many systematic reviews addressing the impact
of teams in health care in chronic diseases such as heart failure
(Holland 2005) and mental illness (Simmonds 2001; Malone
2007), in people at risk of poor nutrition (Naylor 2004) andpeople
with leg or foot ulcers (Nordheim 2014). None of these reviews
have focused on pressure ulcer prevention and management. The
fact that Nordheim 2014 identified only one RCT to include in
their review, suggests that, in the field of wound care, there is a
lack of RCT evidence exploring the impact of wound-care teams.
Due to the lack of studies and reviews in this area, we are unable to
conclude whether this review agrees or disagrees with other studies
or reviews.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Pressure ulcers are a common, costly and debilitating condition.
Use of teams to prevent and manage pressure ulcers is advocated;
however, there is no evidence from independently funded clin-
ical trials to support or refute the use of wound-care teams for
this purpose. Despite this, international guidelines in the field of
wound care recommend the use of a team approach for preventing
and treating pressure ulcers (Moore 2014). Additional research is
needed to demonstrate the effect of the team approach clearly.
Implications for research
The evidence base for use of wound-care teams to prevent and
manage pressure ulcers is very limited, despite the wide use of
these teams. Further trials are justified, based on the incidence
of the problem and the high costs associated with pressure ulcer
prevention and management. Future trials should be large enough
to show meaningful differences; include participant-related out-
comes such as acceptability, adverse events and quality of life; and
economic evaluations to assist healthcare managers to make ratio-
nal decisions. Standard, validated tools should be used to measure
outcomes such as pressure ulcer staging and quality of life.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Stern 2014 Employed a cluster step-wedge design and data could not be extracted for any of our outcomes
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. Risk of bias criteria
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators described a random component in the sequence generation process such as: referring to a random number table;
using a computer random-number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators described a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example, sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
Insufficient information about the sequence generation process to permit judgement of low or high risk of bias to be made.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially numbered drug containers of identical appearance; sequentially numbered, opaque, sealed envelopes.
High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: using an open random allocation schedule (e.g. a list of randomnumbers); assignment envelopes were usedwithout appropriate
safeguards (e.g. if envelopes were unsealed or nonopaque or not sequentially numbered); alternation or rotation; date of birth; case
record number; any other explicitly unconcealed procedure.
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Unclear
Insufficient information available to permit judgement of low or high risk of bias to be made. This is usually the case if the method of
concealment was not described, or not described in sufficient detail to allow a definite judgement, for example, if the use of assignment
envelopes was described, but it remained unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judged that the outcome and the outcome measurement were not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others was unlikely to introduce bias.
High risk of bias
Any one of the following.
• No blinding or incomplete blinding, and the outcome or outcome measurement was likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others was likely to introduce bias.
Unclear
Either of the following.
• Insufficient information available to permit judgement of low or high risk of bias to be made.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following.
• No missing outcome data.
• Reasons for missing outcome data were unlikely to be related to true outcome (for survival data, censoring unlikely to be
introducing bias).
• Missing outcome data were balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk was not enough to have
a clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes was not enough to have a clinically relevant impact on observed effect size.
• Missing data were imputed using appropriate methods.
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High risk of bias
Any one of the following.
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk was enough to
induce clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes was enough to induce clinically relevant bias in observed effect size.
• ’As-treated’ analysis done with substantial departure in the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Either of the following.
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated,
no reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Either of the following.
• The study protocol was available and all of the study’s pre-specified (primary and secondary) outcomes that were of interest in
the review were reported in the pre-specified way.
• The study protocol was not available but it was clear that the published reports included all expected outcomes, including those
that were pre-specified (convincing text of this nature may be uncommon).
High risk of bias
Any one of the following.
• Not all of the study’s pre-specified primary outcomes were reported.
• One or more primary outcomes was reported using measurements, analysis methods or subsets of the data (e.g. sub-scales) that
were not pre-specified.
• One or more of the reported primary outcomes was not pre-specified (unless clear justification for their reporting was provided,
such as an unexpected adverse effect).
• One or more outcomes of interest in the review were reported incompletely so that they could not be entered in a meta-analysis.
• The study report did not include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information was available to permit a judgement of low or high risk of bias to be made. It is likely that the majority of
studies will fall into this category.
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6. Other sources of potential bias
Low risk of bias
The study appeared to be free of other sources of bias.
High risk of bias
There was at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• had extreme baseline imbalance; or
• was claimed to have been fraudulent; or
• had some other problem.
Unclear
There may be a risk of bias, but there was either:
• insufficient information to assess whether an important risk of bias existed; or
• insufficient rationale or evidence that an identified problem would introduce bias.
Appendix 2. Search strategies for Ovid MEDLINE, Ovid EMBASE and EBSCO CINAHL
Ovid MEDLINE
1 exp Patient Care Team/
2 ((care or health or healthcare or medical or nursing or interdisciplinary or multidisciplinary or multidimensional or wound* or turn*)
adj team*).tw.
3 (team nursing or nurse-led or nurse-centred or team-based).tw.
4 or/1-3
5 exp Pressure Ulcer/
6 (pressure adj (ulcer* or sore* or injur*)).tw.
7 (decubitus adj (ulcer* or sore*)).tw.
8 (bedsore* or bed sore*).tw.
9 or/5-8
10 4 and 9
11 randomized controlled trial.pt.
12 controlled clinical trial.pt.
13 randomi?ed.ab.
14 placebo.ab.
15 clinical trials as topic.sh.
16 randomly.ab.
17 trial.ti.
18 or/11-17
19 (animals not (humans and animals)).sh.
20 18 not 19
21 10 and 20
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Ovid EMBASE
1 exp patient care/
2 ((care or health or healthcare or medical or nursing or interdisciplinary or multidisciplinary or multidimensional or wound* or turn*)
adj team*).tw.
3 (team nursing or nurse-led or nurse-centred or team-based).tw.
4 or/1-3
5 exp decubitus/
6 (pressure adj (ulcer* or sore* or injur*)).tw.
7 (decubitus adj (ulcer* or sore*)).tw.
8 (bedsore* or bed sore*).tw.
9 or/5-8
10 4 and 9
11 Randomized controlled trials/
12 Single-Blind Method/
13 Double-Blind Method/
14 Crossover Procedure/
15 (random$ or factorial$ or crossover$ or cross over$ or cross-over$ or placebo$ or assign$ or allocat$ or volunteer$).ti,ab.
16 (doubl$ adj blind$).ti,ab.
17 (singl$ adj blind$).ti,ab.
18 or/11-17
19 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/
20 human/ or human cell/
21 and/19-20
22 19 not 21
23 18 not 22
24 10 and 23
EBSCO CINAHL
S25 S12 AND S24
S24 S13 or S14 or S15 or S16 or S17 or S18 or S19 or S20 or S21 or S22 or S23
S23 MH “Quantitative Studies”
S22 TI placebo* or AB placebo*
S21 MH “Placebos”
S20 TI random* allocat* or AB random* allocat*
S19 MH “Random Assignment”
S18 TI randomi?ed control* trial* or AB randomi?ed control* trial*
S17 AB ( singl* or doubl* or trebl* or tripl* ) and AB ( blind* or mask* )
S16 TI ( singl* or doubl* or trebl* or tripl* ) and TI ( blind* or mask* )
S15 TI clinic* N1 trial* or AB clinic* N1 trial*
S14 PT Clinical trial
S13 MH “Clinical Trials+”
S12 S6 AND S11
S11 S7 OR S8 OR S9 OR S10
S10 TI ( bedsore or bed sore ) or AB ( bedsore or bed sore )
S9 TI ( pressure N1 (ulcer* or sore* or injur*) ) OR AB ( pressure N1 (ulcer* or sore* or injur*) )
S8 TI decubitus or AB decubitus
S7 (MH “Pressure Ulcer”)
S6 S1 OR S2 OR S3 OR S4 OR S5
S5 TI ( “team nursing” or nurse-led or nurse-centred or team-based ) OR AB ( “team nursing” or nurse-led or nurse-centred or team-
based )
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S4 TI ( ((care or health or healthcare or medical or nursing or interdisciplinary or multidisciplinary or multidimensional or wound*
or turn*) N1 team*) ) OR AB ( ((care or health or healthcare or medical or nursing or interdisciplinary or multidisciplinary or
multidimensional or wound* or turn*) N1 team*) )
S3 (MH “Total Patient Care Nursing”)
S2 (MH “Team Nursing”)
S1 (MH “Multidisciplinary Care Team+”)
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